Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial. / Andersen, Kenneth Geving; Gärtner, Rune; Kroman, Niels; Flyger, Henrik; Kehlet, Henrik.

I: Breast, Bind 21, Nr. 1, 2012, s. 46-49.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Andersen, KG, Gärtner, R, Kroman, N, Flyger, H & Kehlet, H 2012, 'Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial', Breast, bind 21, nr. 1, s. 46-49. https://doi.org/10.1016/j.breast.2011.07.011

APA

Andersen, K. G., Gärtner, R., Kroman, N., Flyger, H., & Kehlet, H. (2012). Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial. Breast, 21(1), 46-49. https://doi.org/10.1016/j.breast.2011.07.011

Vancouver

Andersen KG, Gärtner R, Kroman N, Flyger H, Kehlet H. Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial. Breast. 2012;21(1):46-49. https://doi.org/10.1016/j.breast.2011.07.011

Author

Andersen, Kenneth Geving ; Gärtner, Rune ; Kroman, Niels ; Flyger, Henrik ; Kehlet, Henrik. / Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial. I: Breast. 2012 ; Bind 21, Nr. 1. s. 46-49.

Bibtex

@article{76c7a2fb955146e9a0a9d47e1fe5b606,

title = "Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial",

abstract = "Persistent pain after breast cancer treatment (PPBCT) affects between 25 and 60% of patients depending on surgical and adjuvant treatment. External breast radiotherapy (EBRT) has been shown to be a riskfactor for PPBCT, raising the question whether intraoperative radiation therapy (IORT), with its smaller radiation field may reduce the development of PPBCT. Using data from the TARGIT-A trial, the aim of this study was to compare these two treatments with regard to development of PPBCT. A total of 281 patients enrolled in the TARGIT-A trial from the Copenhagen University Hospitals was screened for participation, and a total of 244 patients were included and received a detailed questionnaire. The response rate was 98%, leaving 238 patients for the final analysis. Pain prevalence were 33.9% in the EBRT group and 24.6% in the IORT group (p = 0.11). Treatment with IORT may not alter the risk of PPBCT.",

author = "Andersen, {Kenneth Geving} and Rune G{\"a}rtner and Niels Kroman and Henrik Flyger and Henrik Kehlet",

year = "2012",

doi = "10.1016/j.breast.2011.07.011",

language = "English",

volume = "21",

pages = "46--49",

journal = "Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

number = "1",

}

RIS

TY - JOUR

T1 - Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial

AU - Andersen, Kenneth Geving

AU - Gärtner, Rune

AU - Kroman, Niels

AU - Flyger, Henrik

AU - Kehlet, Henrik

PY - 2012

Y1 - 2012

N2 - Persistent pain after breast cancer treatment (PPBCT) affects between 25 and 60% of patients depending on surgical and adjuvant treatment. External breast radiotherapy (EBRT) has been shown to be a riskfactor for PPBCT, raising the question whether intraoperative radiation therapy (IORT), with its smaller radiation field may reduce the development of PPBCT. Using data from the TARGIT-A trial, the aim of this study was to compare these two treatments with regard to development of PPBCT. A total of 281 patients enrolled in the TARGIT-A trial from the Copenhagen University Hospitals was screened for participation, and a total of 244 patients were included and received a detailed questionnaire. The response rate was 98%, leaving 238 patients for the final analysis. Pain prevalence were 33.9% in the EBRT group and 24.6% in the IORT group (p = 0.11). Treatment with IORT may not alter the risk of PPBCT.

AB - Persistent pain after breast cancer treatment (PPBCT) affects between 25 and 60% of patients depending on surgical and adjuvant treatment. External breast radiotherapy (EBRT) has been shown to be a riskfactor for PPBCT, raising the question whether intraoperative radiation therapy (IORT), with its smaller radiation field may reduce the development of PPBCT. Using data from the TARGIT-A trial, the aim of this study was to compare these two treatments with regard to development of PPBCT. A total of 281 patients enrolled in the TARGIT-A trial from the Copenhagen University Hospitals was screened for participation, and a total of 244 patients were included and received a detailed questionnaire. The response rate was 98%, leaving 238 patients for the final analysis. Pain prevalence were 33.9% in the EBRT group and 24.6% in the IORT group (p = 0.11). Treatment with IORT may not alter the risk of PPBCT.

U2 - 10.1016/j.breast.2011.07.011

DO - 10.1016/j.breast.2011.07.011

M3 - Journal article

VL - 21

SP - 46

EP - 49

JO - Breast

JF - Breast

SN - 0960-9776

IS - 1

ER -

ID: 40169139